Dose-response study of caffeine effects on cerebral functional activity with a specific focus on dependence

Brain Research

Volumn 858, Issue 1, 2000, Pages 71-77

  Neblig, Astrid ^a   Boyet, Sylvette ^a  

^a INSERM   (France)

Author keywords

Caffeine; Cerebral glucose utilization; Dependence; Locomotion; Sleep

Indexed keywords

CAFFEINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG DEPENDENCE; GLUCOSE UTILIZATION; LOCOMOTION; LOCUS CERULEUS; MALE; MOOD; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SLEEP;

AMYGDALA; ANIMALS; BLOOD GLUCOSE; BRAIN; CAFFEINE; CAUDATE NUCLEUS; CEREBRAL CORTEX; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENOUS; MALE; MESENCEPHALON; NUCLEUS ACCUMBENS; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE-RELATED DISORDERS; THALAMUS;

EID: 0033975014     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02480-4     Document Type: Article

References (44)

1. G.F. Alheid, L. Heimer, New perspectives in basal forebrain organization of special relevance for neuropsychiatrie disorders; the striatopallidal, amygdaloid, and corticopetal components of the substantia innominata, Neuroscience 27 (1988) 1-39.
2. J.J. Barone, H.R. Roberts, Caffeine consumption, Food Chem. Toxicol. 34 (1996) 119-126.
3. D.T. Chou, J.H. Forde, K.R. Hirsh, Unit activity in medial thalamus, comparative effects of caffeine and amphetamine, J. Pharmacol. Exp. Ther. 213 (1980) 580-585.
4. M. Davis, The role of amygdala in fear and anxiety, Annu. Rev. Neurosci. 15 (1992) 353-375.
5. G. Di Chiara, A. Imperato, Drugs abused in humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats, Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 5274-5278.
6. G. Di Chiara, The role of dopamine in drug abuse viewed from the perspective of its role in motivation, Drug Alcohol Depend. 38 (1995) 95-137.
7. S. Ferré, K. Fuxe, G. von Euler, B. Johansson, B.B. Fredholm, Adenosine-dopamine interactions in the brain, Neuroscience 51 (1992) 501-512.
8. B.B. Fredholm, Adenosine, adenosine receptors and the actions of caffeine, Pharmacol. Toxicol. 76 (1995) 93-101.
9. S.C. Gerson, R.J. Baldessarini, Motor effects of serotonin in the central nervous system, Life Sci. 27 (1980) 1435-1451.
10. A.M. Graybiel, R. Moratalla, H.A. Robertson, Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum, Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 6912-6916.
11. R.R. Griffiths, S.M. Evans, S.J. Heishman, K.L. Preston, C.A. Sannerud, B. Wolf, P.P. Woodson, Low-dose caffeine physical dependence in humans, J. Pharmacol. Exp. Ther. 255 (1990) 1123-1132.
12. R.R. Griffiths, G.K. Mumford, Caffeine - a drug of abuse?, in: F.E. Bloom, D.J. Kupfer (Eds.), Psychopharmacology, The Fourth Generation of Progress, Raven Press, New York, 1995, pp. 1699-1713.
13. R.R. Griffiths, G.K. Mumford, Caffeine reinforcement, discrimination, tolerance and physical dependence in laboratory animals and humans, in: C.R. Schuster, M.J. Kuhar (Eds.), Handbook of Experimental Pharmacology, Vol. 118, Springer, Heidelberg, 1996, pp. 315-341.
14. R.R. Griffiths, P.P. Woodson, Caffeine physical dependence, a review of human and laboratory animal studies, Psychopharmacology 94 (1988) 437-451.
15. L. Heimer, D.S. Zahm, L. Churchill, P.W. Kalivas, C. Wohltmann, Specificity in the projection patterns of accumbal core and shell in the rat, Neuroscience 41 (1991) 89-125.
16. K. Hirsh, K. Central nervous system pharmacology of the dietary methylxanthines, in: G.A. Spiller (Ed.), The Methylxanthine Beverages and Food, Chemistry, Consumption and Health Effects, Alan Liss, New York, 1984, pp. 235-301.
17. 4 on single unit activity in the caudate nucleus, Soc. Neurosci. Abstr. 8 (1982) 898, abstract.
18. S.G. Holtzman, Caffeine as a model drug of abuse, Trends Pharmacol. Sci. 11 (1990) 355-356.
19. J.E. James, Caffeine and Health, Academic Press, London, 1991.
20. B. Johansson, K. Lindström, B.B. Fredholm, Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat, Neuroscience 59 (1994) 837-849.
21. M. Jouvet, Biogenic amines and the states of sleep, Science 163 (1969) 32-41.
22. A. Liguori, J.R. Hughes, K. Goldberg, P. Callas, Subjective effects of oral caffeine in formerly cocaine-dependent humans, Drug Alcohol Depend. 49 (1997) 17-24.
23. B.A. McMillen, CNS stimulants, two distinct mechanisms of action for amphetamine-like drugs, Trends Pharmacol. Sci. 4 (1983) 429-432.
24. A. Nehlig, J.L. Daval, G. Debry, Caffeine and the central nervous system, mechanisms of action, biochemical, metabolic and psychostimulant effects, Brain Res. Rev. 17 (1992) 139-170.
25. A. Nehlig, J.L. Daval, S. Boyet, P. Vert, Comparative effects of acute and chronic administration of caffeine on local cerebral glucose utilization in the conscious rat, Eur. J. Pharmacol. 129 (1986) 93-103.
26. A. Nehlig, G. Lucignani, M. Kadekaro, L.J. Porrino, L. Sokoloff, Effects of acute administration of caffeine on local cerebral glucose utilization in the rat, Eur. J. Pharmacol. 101 (1984) 91-100.
27. A. Nehlig, A. Pereira de Vasconcelos, A. Collignon, S. Boyet, Comparative effects of caffeine and L-phenylisopropyladenosine on local cerebral glucose utilization in the rat, Eur. J. Pharmacol. 157 (1988) 1-10.
28. M. Okada, K. Kiryu, Y. Kawata, K. Mizuno, K. Wada, H. Tasaki, S. Kaneko, Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis, Eur. J. Pharmacol. 321 (1997) 181-188.
29. M. Okada, K. Mizuno, S. Kaneko, Adenosine Al and A2 receptors modulate extracellular dopamine levels in rat striatum, Neurosci. Lett. 212 (1996) 53-56.
30. F. Orzi, F. Passarelli, M. La Riccia, R. Di Grezia, F.E. Pontieri, Intravenous morphine increases glucose utilization in the shell of the rat nucleus accumbens, Eur. J. Pharmacol. 302 (1996) 49-51.
31. B.G. Phillips-Bute, J.D. Lane, Caffeine withdrawal symptoms following brief caffeine deprivation, Physiol. Behav. 63 (1998) 35-39.
32. F.E. Pontieri, G. Tanda, G. Di Chiara, Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens, Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 12304-12308.
33. F.E. Pontieri, G. Tanda, F. Orzi, G. Di Chiara, Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs, Nature 382 (1996) 255-257.
34. L.J. Porrino, F.R. Domer, A.M. Crane, L. Sokoloff, Selective alterations in cerebral metabolism within the mesocorticolimbic dopaminergic system produced by acute cocaine administration in rats, Neuropsychopharmacology 1 (1988) 109-118.
35. S. Reinis, J.M. Goldman, The Chemistry of Behavior. A Molecular Approach to Neuronal Plasticity, Plenum, New York, 1982.
36. P.J. Rogers, C. Dernoncourt, Regular caffeine consumption, a balance of adverse and beneficial effects for mood and psychomotor performance, Pharmacol. Biochem. Behav. 59 (1998) 1039-1045.
37. D.W. Self, E.J. Nestler, Molecular mechanisms of drug reinforcement and addiction, Annu. Rev. Neurosci. 18 (1995) 463-495.
38. J. Snel, Coffee and caffeine. Sleep and wakefulness, in: S. Garattini (Ed.), Coffee, Caffeine and Health, Raven Press, New York, 1993, pp. 255-290.
39. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization, theory, procedure, and normal values in the conscious and anesthetized albino rat, J. Neurochem. 28 (1977) 897-916.
40. E.A. Stein, S.A. Fuller, Selective effects of cocaine on regional cerebral blood flow in the rat, J. Pharmacol. Exp. Ther. 262 (1992) 327-334.
41. E.C. Strain, G.K. Mumford, K. Silverman, R.R. Griffiths, Caffeine dependence syndrome. Evidence from case histories and experimental evaluations, JAMA 272 (1994) 1043-1048.
42. P. Svenningsson, A. Ström, B. Johansson, B.B. Fredholm, Increased expression of c-jun, junB, AP-1, and preproenkephalin mRNA in rat striatum following a single injection of caffeine, J. Neurosci. 15 (1995) 3583-3593.
43. P. Svenningsson, G.G. Nomikos, B.B. Fredholm, Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following an acute caffeine administration, J. Neurosci. 15 (1995) 7612-7624.
44. G. Tanda, P. Loddo, R. Frau, E. Acquas, G. Di Chiara, Effect of intravenous caffeine on limbic and cortical dopamine transmission in the rat, a microdialysis study, Proceedings of the 6th International Symposium on Adenosine and Adenine Nucleotides, Ferrara, Italy, May 19-24, 1998.